Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The DNA Microarray Market Size Shifted, And What Is the Outlook Through 2034?

The market size for DNA microarray has experienced substantial growth in the last few years. Its size is projected to increase from $3.38 billion in 2024 to $3.79 billion in 2025, representing a compound annual growth rate (CAGR) of 12.3%. The historic period’s growth can be traced back to developments in pharmacogenomics, enhancements in healthcare infrastructure, alliances and partnerships, reduction in cost, and an increase in public awareness and education.

How Much Will the DNA Microarray Market Be Worth in 2029?

In the coming years, we can anticipate a significant expansion in the DNA microarray market. The projection predicts an increase to $5.98 billion by 2029 with a compound annual growth rate (CAGR) of 12.1%. Contributing factors to this potential growth include developments in personalized medical treatments, the appearance of comparative genomic hybridization (CGH), growth in agricultural genomics, proper regulatory approvals and standards, and an increasing occurrence of chronic diseases. The major tendencies predicted for this phase include advancements in genomic studies, augmented funding for these studies, technological breakthroughs, interconnection with other technologies, and overall progress in technology.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16039&type=smp

Which is the Largest Company in the DNA Microarray Market?

Major companies operating in the DNA microarray market are Roche Holding AG, Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Agilent Technologies Inc., PerkinElmer Inc., Illumina Inc., bioMérieux SA, Schott AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Bioneer Corporation, CapitalBio Technology Co. Ltd., Eurofins Genomics LLC, Savyon Diagnostics Ltd., Oxford Gene Technology, Sengenics Corporation LLC, Affymetrix, BioCat GmbH, Scienion AG, LC Sciences, Arrayit Corporation, Akonni Biosystems Inc., Arraystar Inc., Febit Holding GmbH

What Are the Main Market Drivers in the DNA Microarray Industry?

The DNA microarray market’s expansion is predicted to skyrocket due to the fast acceptance of personalized medicine. This tailored medical treatment takes into account the specific characteristics of each patient, including genetic, environmental, and lifestyle factors, to maximize the effectiveness and outcomes of the therapy. The swift advent of ‘omics’ technology, data amalgamation, genetics, and the understanding of the importance of customized patient-specific medications and preventive measures have all contributed to the rise of personalized medicine. DNA microarrays assist in personalized healthcare by examining gene expression patterns, which in turn enable customised treatment plans drawn from an individual’s genetic profile. The Personalized Medicine Coalition, a not-for-profit organization based in the United States, reported in February 2024 that the FDA had authorized 16 new targeted therapies for patients with rare diseases in 2023, a substantial increase from the 6 approved in 2022. Consequently, the speedy uptake of personalized medicine is fueling the growth of the DNA microarray market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16039&type=smp

How Is the DNA Microarray Market Segments Structured?

The DNA microarray market covered in this report is segmented –

1) By Type: Complementary DNA Microarrays, Oligonucleotide DNA Microarrays, Other Types

2) By Application: Gene Expression Analysis, Genotyping, Other Applications

3) By End-user: Pharmaceutical And Biotechnology Companies, Diagnostic Centers, Hospitals And Clinics, Academic And Research Institute, Other End-Users

Subsegments:

1) By Complementary DNA Microarrays: Gene Expression Profiling, Comparative Genomic Hybridization (CGH), Quantitative Analysis

2) By Oligonucleotide DNA Microarrays: Gene Expression Microarrays, Single Nucleotide Polymorphism (SNP) Arrays, DNA Methylation Arrays, Pathogen Detection Arrays

3) By Other Types: Protein-DNA Microarrays, Tissue Microarrays, Affinity Microarrays, Spotted DNA Microarrays

What Strategic Trends Are Transforming the DNA Microarray Market?

Leading businesses in the DNA microarray market are honing their competitive edge by focusing on the evolution of innovative technology capable of enabling a two-day turnaround time. The ability of microarray analysis to facilitate swift and effective results within this timeframe significantly expedites both research and clinical decision-making processes. Demonstrating this, Thermo Fisher Scientific Inc., hailing from the US, unveiled the Applied Biosystems CytoScan HD Accel array in August 2023. This new chromosomal microarray is primarily aimed at boosting productivity, efficiency, and profitability within cytogenetic research laboratories through its impressive two-day turnaround time. With its capacity for in-depth analysis of the whole genome across over 5,000 critical genomic regions, the CytoScan HD Accel array offers valuable insights into chromosomal variants, making it a versatile tool for prenatal, postnatal, and oncology research.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/dna-microarray-global-market-report

Which Global Regions Offer the Highest Growth in the DNA Microarray Market?

North America was the largest region in the DNA microarray market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the DNA microarray market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16039

This Report Delivers Insight On:

1. How big is the dna microarray market, and how is it changing globally?

2. Who are the major companies in the dna microarray market, and how are they performing?

3. What are the key opportunities and risks in the dna microarray market right now?

4. Which products or customer segments are growing the most in the dna microarray market?

5. What factors are helping or slowing down the growth of the dna microarray market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model